PNP기술 이용한 NK 세포치료제 개발 중최원종 옴니아메드 대표가 1일(현지시간) 독일 베를린에서 개최된 '제11회 국제 mRNA 컨퍼런스'(International mRNA Health Conference)에서 발표를 하고 있다./옴니아메드 제관련 키워드gbf관련 기사Why South Korea's Bio Industry Needs 10-Year Support Plans: Insights from GBF 2026The Future of Medicine: Why South Korea Must Invest in Innovative Drug DevelopmentHow South Korea's Regulatory Innovations are Shaping the Global Bio Market in 2026Unlocking Global Markets: Key Strategies for Successful FDA Approval in 2026Revolutionizing Drug Development: How Quantum Computing and AI Can Overcome the 4% Success Rate